Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Infections 1 Hematologic Neoplasms 1 Agammaglobulinemia 1

Interventions

Rituximab 19 zanubrutinib 13 acalabrutinib 11 Magnetic Resonance Spectroscopy 11 obinutuzumab 10 Specimen Handling 10 Cyclophosphamide 10 Biopsy 9 glofitamab 8 Bendamustine Hydrochloride 8 pirtobrutinib 7 fludarabine 7 venetoclax 6 orelabrutinib 6 Lenalidomide 5 Cytarabine 5 ibrutinib 4 fludarabine phosphate 3 Immunotherapy, Adoptive 3 CT-P10 3 tafasitamab 2 polatuzumab vedotin 2 loncastuximab tesirine 2 brexucabtagene autoleucel 2 Whole-Body Irradiation 2 Therapeutics 2 Prednisone 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Mantle-Cell × Immunoglobulins × Clear all

NCT05910801 2024-11-18

V-MIND

Academic and Community Cancer Research United

Phase 2 Recruiting

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡